Palmitate Induces Tumor Necrosis Factor-α Expression in C2C12 Skeletal Muscle Cells by a Mechanism Involving Protein Kinase C and Nuclear Factor-κB Activation
The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
The mechanisms responsible for increased expression of TNF-α in skeletal muscle cells in diabetic states are not well understood. We examined the effects of the saturated acid palmitate on TNF-α expression. Exposure of C2C12 skeletal muscle cells to 0.75 mm palmitate enhanced mRNA (25-fold induction, P < 0.001) and protein (2.5-fold induction) expression of the proinflammatory cytokine TNF-α. This induction was inversely correlated with a fall in GLUT4 mRNA levels (57% reduction, P < 0.001) and glucose uptake (34% reduction, P < 0.001). PD98059 and U0126, inhibitors of the ERK-MAPK cascade, partially prevented the palmitate-induced TNF-α expression. Palmitate increased nuclear factor (NF)-κB activation and incubation of the cells with the NF-κB inhibitors pyrrolidine dithiocarbamate and parthenolide partially prevented TNF-α expression. Incubation of palmitate-treated cells with calphostin C, a strong and specific inhibitor of protein kinase C (PKC), abolished palmitate-induced TNF-α expression, and restored GLUT4 mRNA levels. Palmitate treatment enhanced the expression of phospho-PKCθ, suggesting that this PKC isoform was involved in the changes reported, and coincubation of palmitate-treated cells with the PKC inhibitor chelerythrine prevented the palmitate-induced reduction in the expression of IκBα and insulin-stimulated Akt activation. These findings suggest that enhanced TNF-α expression and GLUT4 down-regulation caused by palmitate are mediated through the PKC activation, confirming that this enzyme may be a target for either the prevention or the treatment of fatty acid-induced insulin resistance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PKCθ is predominantly expressed in skeletal muscle and endothelium and is activated by increased DAG content in muscles, via elevated plasma fatty acid infusion in humans [80] or palmitate treatment in myocytes [64].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [64]
Citations
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Protein kinase C and lipid signaling for sustained cellular responses
Nishizuka, Y. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.7.7737456 · Cited by 2,499
Andrews, N. C., & Faller, D. V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.9.2499 · Cited by 2,312
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E. (2001) · Science · doi:10.1126/science.1061620 · Cited by 1,884
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Itani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link
Hotamisligil, G. S., & Spiegelman, B. M. (1994) · Diabetes · doi:10.2337/diab.43.11.1271 · Cited by 1,281
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Chelerythrine is a potent and specific inhibitor of protein kinase C
Herbert, J. M., Augereau, J. M., Gleye, J., & Maffrand, J. P. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)91544-3 · Cited by 1,195
Activation in vitro of NF-κB" by phosphorylation of its inhibitor IκB"
Ghosh, S., & Baltimore, D. (1990) · Nature · doi:10.1038/344678a0 · Cited by 1,172
Quantitative RT-PCR: Pitfalls and Potential
Freeman, W. M., Walker, S. J., & Vrana, K. E. (1999) · BioTechniques · doi:10.2144/99261rv01 · Cited by 1,147
Perseghin, G., Scifo, P., De Cobelli, F., Pagliato, E., Battezzati, A., Arcelloni, C., Vanzulli, A., Testolin, G., Pozza, G., Del Maschio, A., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.8.1600 · Cited by 877
Prevention of fat-induced insulin resistance by salicylate
Kim, J. K., Kim, Y.-J., Fillmore, J. J., Chen, Y., Moore, I., Lee, J., Yuan, M., Li, Z. W., Karin, M., Perret, P., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11559 · Cited by 737
The expression of TNF alpha by human muscle. Relationship to insulin resistance.
Saghizadeh, M., Ong, J. M., Garvey, W. T., Henry, R. R., & Kern, P. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118504 · Cited by 717
Malonyl-CoA, fuel sensing, and insulin resistance
Ruderman, N. B., Saha, A. K., Vavvas, D., & Witters, L. A. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.276.1.e1 · Cited by 650
Chavez, J. A., Knotts, T. A., Wang, L.-P., Li, G., Dobrowsky, R. T., Florant, G. L., & Summers, S. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212307200 · Cited by 617 · cited 2×
“cells (19, 24) because concentrations of FFA up to 2 mm are”
BackgroundSchmitz-Peiffer, C., Craig, D. L., & Biden, T. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24202 · Cited by 592
Poynter, M. E., & Daynes, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32833 · Cited by 550
Miyake, Y., Kozutsumi, Y., Nakamura, S., Fujita, T., & Kawasaki, T. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.1827 · Cited by 536
Effects of fat on insulin-stimulated carbohydrate metabolism in normal men.
Boden, G., Jadali, F., White, J., Liang, Y., Mozzoli, M., Chen, X., Coleman, E., & Smith, C. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115399 · Cited by 500
PKC-θ knockout mice are protected from fat-induced insulin resistance
Kim, J. K., Fillmore, J. J., Sunshine, M. J., Albrecht, B., Higashimori, T., Kim, D.-W., Liu, Z.-X., Soos, T. J., Cline, G. W., O’Brien, W. R., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422230 · Cited by 500
Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2
Kido, Y., Burks, D. J., Withers, D., Bruning, J. C., Kahn, C. R., White, M. F., & Accili, D. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7917 · Cited by 492
de Alvaro, C., Teruel, T., Hernandez, R., & Lorenzo, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312021200 · Cited by 428
Metabolic Disturbances and Wasting in the Acquired Immunodeficiency Syndrome
Flier, J. S., Underhill, L. H., Grunfeld, C., & Feingold, K. R. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207303270506 · Cited by 398
Protein Kinase C θ Inhibits Insulin Signaling by Phosphorylating IRS1 at Ser1101
Li, Y., Soos, T. J., Li, X., Wu, J., DeGennaro, M., Sun, X., Littman, D. R., Birnbaum, M. J., & Polakiewicz, R. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400186200 · Cited by 358
Paumen, M. B., Ishida, Y., Muramatsu, M., Yamamoto, M., & Honjo, T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.6.3324 · Cited by 349 · cited 1×
“Because palmitoyl-coenzyme A is a precursor of sphingolipid synthesis, palmitate treatment may result in enhanced synthesis of ceramides (26), which can attenuate insulin signaling pathways leading to insulin resistance (19).”
BackgroundEffects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes.
Boden, G., & Chen, X. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118160 · Cited by 344
Hehner, S. P., Heinrich, M., Bork, P. M., Vogt, M., Ratter, F., Lehmann, V., Schulze-Osthoff, K., Dröge, W., & Schmitz, M. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1288 · Cited by 338
Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling.
Peraldi, P., Xu, M., & Spiegelman, B. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119715 · Cited by 314
Schmitz-Peiffer, C., Browne, C. L., Oakes, N. D., Watkinson, A., Chisholm, D. J., Kraegen, E. W., & Biden, T. J. (1997) · Diabetes · doi:10.2337/diab.46.2.169 · Cited by 314
The ups and downs of MEK kinase interactions
Hagemann, C., & Blank, J. L. (2001) · Cellular Signalling · doi:10.1016/s0898-6568(01)00220-0 · Cited by 275
Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity.
Itani, S. I., Zhou, Q., Pories, W. J., MacDonald, K. G., & Dohm, G. L. (2000) · Diabetes · doi:10.2337/diabetes.49.8.1353 · Cited by 233
Liu, L. S., Spelleken, M., Röhrig, K., Hauner, H., & Eckel, J. (1998) · Diabetes · doi:10.2337/diabetes.47.4.515 · Cited by 178
Manco, M., Greco, A. V., Capristo, E., Gniuli, D., De Gaetano, A., & Gasbarrini, G. (2000) · Metabolism · doi:10.1016/s0026-0495(00)91377-5 · Cited by 175
KOBAYASHI, E., ANDO, K., NAKANO, H., IIDA, T., OHNO, H., MORIMOTO, M., & TAMAOKI, T. (1989) · The Journal of Antibiotics · doi:10.7164/antibiotics.42.1470 · Cited by 146
Tumor Necrosis Factor Not Detectable in Patients With Clinical Cancer Cachexia
Socher, S. H., Martinez, D., Craig, J. B., Kuhn, J. G., & Oliff, A. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.8.595 · Cited by 128
Cabrero, A., Alegret, M., Sánchez, R. M., Adzet, T., Laguna, J. C., & Vázquez, M. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1883 · Cited by 124
Self-citationProtein kinase C modulates insulin action in human skeletal muscle
Cortright, R. N., Azevedo, J. L., Zhou, Q., Sinha, M., Pories, W. J., Itani, S. I., & Dohm, G. L. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.3.e553 · Cited by 100
Diacylglycerol activation of protein kinase C is modulated by long-chain acyl-CoA
Bronfman, M., Morales, M. N., & Orellana, A. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80381-4 · Cited by 95
Heydrick, S. J., Ruderman, N. B., Kurowski, T. G., Adams, H. B., & Chen, K. S. (1991) · Diabetes · doi:10.2337/diab.40.12.1707 · Cited by 89
Mingrone, G., Rosa, G. D., Rocco, P. D., Manco, M., Capristo, E., Castagneto, M., Vettor, R., Gasbarrini, G. B., & Greco, A. V. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802053 · Cited by 82
Fabris, R., Nisoli, E., Lombardi, A. M., Tonello, C., Serra, R., Granzotto, M., Cusin, I., Rohner-Jeanrenaud, F., Federspil, G., Carruba, M. O., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.3.601 · Cited by 80
Identification of Two Essential Phosphorylated Threonine Residues In the Catalytic Domain of Mekk1
Siow, Y. L., Kalmar, G. B., Sanghera, J. S., Tai, G., Oh, S. S., & Pelech, S. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7586 · Cited by 70
Górski, J., Nawrocki, A., & Murthy, M. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006820907955 · Cited by 51
Interaction of AP-1 with a Cluster of NF-κB Binding Elements in the Human TNF Promoter Region
Udalova, I. A., & Kwiatkowski, D. P. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5929 · Cited by 27
Udalova, I. A., Vidal, V., Scragg, I. G., & Kwiatkowski, D. P. (2000) · Infection and Immunity · doi:10.1128/iai.68.9.5447-5449.2000 · Cited by 7
Cited by
Kaur, R., Kaur, M., & Singh, J. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0763-3 · Cited by 736
Endothelial dysfunction — A major mediator of diabetic vascular disease
Sena, C. M., Pereira, A. M., & Seiça, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.006 · Cited by 797
SIRT1 Improves Insulin Sensitivity under Insulin-Resistant Conditions by Repressing PTP1B
Sun, C., Zhang, F., Ge, X., Yan, T., Chen, X., Shi, X., & Zhai, Q. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.014 · Cited by 766
Skeletal muscle inflammation and insulin resistance in obesity
Wu, H., & Ballantyne, C. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88880 · Cited by 695
Kennedy, A., Martinez, K., Chuang, C.-C., LaPoint, K., & McIntosh, M. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.098269 · Cited by 560
Metadata
- Authors
- Jové, M., Planavila, A., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez-Carrera, M.
- Affiliations
- Pharmacology Unit, Department of Pharmacology and Therapeutic Chemistry, Faculty of Pharmacy, University of Barcelona, E-08028 Barcelona, Spain
- Universitat de Barcelona (ES)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2006-01-01
- Volume
- 147
- Issue
- 1
- Pages
- 552-561
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2005040360
- Cited by
- 172
- References
- 50
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 4 · 2021: 4 · 2020: 7 · 2019: 5 · 2018: 8 · 2017: 5 · 2016: 5 · 2015: 18 · 2014: 13 · 2013: 13 · 2012: 8
- FWCI
- 7.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- European Commission
- Generalitat de Catalunya
- Universitat de Barcelona
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- palmitate, TNF-α, skeletal muscle, C2C12 myoblasts, protein kinase C, PKC theta, NF-κB, GLUT4, glucose uptake, insulin resistance, ERK MAPK, saturated fatty acids, diabetes mellitus, Akt, chelerythrine, pyrrolidine dithiocarbamate, parthenolide
- MeSH terms
- Alkaloids, Animals, Biological Transport, Cell Line, Enzyme Inhibitors, Glucose, Naphthalenes, Phenanthridines, Protein Kinase C, Pyrrolidines, Sesquiterpenes, Thiocarbamates, Tumor Necrosis Factor-alpha, NF-kappa B, Muscle, Skeletal, Palmitic Acid, Mice, Benzophenanthridines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.